Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Targeted treatment of solid tumors and hematologic malignancies.
Approved for use in oncology care according to FDA-approved indications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
Adult patients with unresectable or metastatic HER2-positive breast cancer, HER2-low breast cancer, HER2-mutant metastatic NSCLC, and locally advanced or metastatic HER2-positive gastric adenocarcinoma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
NTRK gene fusion-positive solid tumors across all tissue origins.
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.